Company profile for Biossil

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Biossil is a biotechnology company dedicated to developing targeted therapies for biologically defined patient subgroups. Focused on diseases where traditional drug discovery has struggled due to population variability, Biossil applies advanced scientific and technological approaches to accelerate precision treatment development. Driven by innovation and efficiency, our mission is to significantly reduce the time and cost of b...
Biossil is a biotechnology company dedicated to developing targeted therapies for biologically defined patient subgroups. Focused on diseases where traditional drug discovery has struggled due to population variability, Biossil applies advanced scientific and technological approaches to accelerate precision treatment development. Driven by innovation and efficiency, our mission is to significantly reduce the time and cost of bringing new, effective therapies to patients, marking the last lap in faster, smarter drug development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
901 S. Central Expressway, Richardson, TX 75080
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-10-23/medivir-enters-exclusive-licensing-agreement-with-biossil-inc-for-remetinostat

PHARMIWEB
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/22/3170932/0/en/Galera-Therapeutics-Announces-Acquisition-of-Dismutase-Mimetics-Portfolio-by-Toronto-based-Biossil-for-up-to-105-Million.html

GLOBENEWSWIRE
22 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty